vimarsana.com

Page 16 - ரோசாலிண்ட் பிராங்க்ளின் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA advisers meet to review Moderna s coronavirus vaccine

Share it On Thursday, a committee of advisers to the Food and Drug Administration met for the second time in as many weeks to review an experimental coronavirus vaccine. The panel last week endorsed Pfizer and BioNTech s shot, clearing the way for the regulator to issue a historic emergency authorization the next day, and this week convened to review Moderna s candidate. Both vaccines were found in large trials of tens of thousands of volunteers to be strongly effective, preventing COVID-19 in nearly all participants who received them. FDA scientists affirmed the companies claims in their own reviews, issuing detailed analysis of Pfizer and BioNTech s data last week and of Moderna s this Tuesday.

Rosalind Franklin University researcher elected AAAS Fellow

 E-Mail IMAGE: Judith Potashkin, PhD, Professor of Cellular and Molecular Pharmacology and Director of Faculty Affairs for Chicago Medical School at Rosalind Franklin University of Medicine and Science, has been elected to. view more  Credit: Mike Schmidt NORTH CHICAGO, ILLINOIS Judith Potashkin, PhD, Professor of Cellular and Molecular Pharmacology and Director of Faculty Affairs for Chicago Medical School at Rosalind Franklin University of Medicine and Science, has been elected to the rank of fellow by the American Association for the Advancement of Science (AAAS) for her research on Parkinson s and Alzheimer s diseases. At RFU s Center for Neurodegenerative Diseases and Therapeutics, Dr. Potashkin and her team have identified dysregulated pathways and molecular networks in Parkinson s and Alzheimer s disease and other forms of dementia, as well as new biomarkers for Parkinson s disease.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.